FDA clears first VR-based tool for for lower-back pain


The Food and Drug Administration granted the company de novo clearance for its VR programs to help reduce chronic lower back pain. AppliedVR’s eight-week program is based on cognitive behavioral therapy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.